Afrezza is an FDA-approved medication for adults with type 1 or type 2 diabetes. Talk to your healthcare provider to see if Afrezza is right for you.
MannKind is committed to helping people gain access to Afrezza.
MannKind Cares supports people with diabetes and caregivers who have questions about Afrezza. We understand the challenges people may face with the healthcare system and are here to help. MannKind Cares provides support services to help answer your questions related to insurance coverage, prescription cost, and product use.
If your doctor recommends Afrezza for you, ask your physician about enrolling you in MannKind Cares. We will work with your insurance provider to check whether Afrezza is covered and provide support to get your prescription filled. Please contact us if you have questions.
Use these questions to start the conversation with your healthcare provider.
The FEV1 test is a simple breathing test your healthcare provider can perform in their office. This test is done before starting Afrezza to establish a baseline reading. After the baseline has been established, your healthcare provider may test at 6 months and once a year after that. The test measures how an individual inhales or exhales volumes of air and is used to monitor your lung function over time.
Looking for a doctor who has experience prescribing Afrezza? Do you have questions about Afrezza and managing your diabetes? Search for a doctor by zip code or state using the drop-down menu below.* Our list is constantly growing, so check back regularly for updates.
*This physician locator tool is provided by MannKind Corp. (“MannKind”) solely to assist you in locating a physician who has experience with Afrezza. This physician locator tool should not be construed in any way as an endorsement or recommendation by MannKind as to the qualifications of any physicians listed in this tool or the quality of medical care they can provide. MannKind makes no guarantees that using a physician from this list will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. MannKind recommends that you meet and discuss the benefits and risks of treatments and the procedure to administer the product with the potential physician.
MannKind and its affiliates hereby disclaim any and all liability arising from your use of and/or reliance on the information contained in this physician locator tool.
With the Afrezza Patient Savings Card, you may pay as little as $15 for each inhaled insulin prescription depending on your insurance coverage. Terms and conditions apply.**
**Offer is not valid for patients if their prescriptions are paid in part or in full by any state or federally funded programs, including, but not limited to, Medicare or Medicaid, Medigap, VA, DOD or TRICARE. Offer is not valid, where prohibited by law. MannKind Corporation reserves the right to rescind, revoke, or amend this offer without notice. Maximum benefit may vary based on NDC for the duration of the program. Eligibility criteria: Only patients who reside in the United States, Puerto Rico, Guam or the U.S. Virgin Islands can participate in this program. If you have any questions about this program, please call 855-262-5296, or if you have questions about Afrezza, talk to your healthcare professional.
Afrezza can cause serious side effects, including: Sudden lung problems (bronchospasms). Do not use Afrezza if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting Afrezza, your healthcare provider will give you a breathing test to check how your lungs are working.
What is the most important information I should know about Afrezza? Afrezza can cause serious side effects, including: Sudden lung problems (bronchospasms). Do not use Afrezza if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD).
Afrezza can cause serious side effects, including:
Sudden lung problems (bronchospasms). Do not use Afrezza if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting Afrezza, your healthcare provider will give you a breathing test to check how your lungs are working.
Do not use Afrezza if you:
Before using Afrezza, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins or herbal supplements.
Before you start using Afrezza, talk to your healthcare provider about low blood sugar and how to manage it.
While using Afrezza do not:
Afrezza may cause serious side effects that can lead to death, including:
See “What is the most important information I should know about Afrezza?” at the top of this page.
Treatment with TZDs and Afrezza may need to be changed or stopped by your healthcare provider if you have new or worse heart failure.
Get emergency medical help if you have:
• Trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, confusion.
The most common side effects of Afrezza include:
These are not all the possible side effects of Afrezza. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 (1-800-332-1088).
Active ingredient: human insulin
Inactive ingredients: fumaryl diketopiperazine, polysorbate 80
General information about the safe and effective use of Afrezza.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use Afrezza for a condition for which it was not prescribed. Do not give Afrezza to other people, even if they have the same symptoms that you have. It may harm them.
This Medication Guide summarizes the most important information about Afrezza. If you would like more information, talk with your healthcare provider. You can ask your pharmacist or healthcare provider for information about Afrezza that is written for health professionals. For more information, go to www.afrezza.com or call MannKind Corp. 1-877-323-8505.